The article discusses tensions between supporters of RFK Jr.'s Make America Healthy Again (MAHA) agenda and China hawks over peptide drugs, which China manufactures and some in the MAHA movement advocate for. The piece explores the intersection of health policy preferences and geopolitical concerns regarding Chinese pharmaceutical supply chains.